orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.
Company profile
Ticker
ORGS
Exchange
Website
CEO
Vered Caplan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Orgenesis, Inc., Business Outsourcing Service, Inc.
SEC CIK
Corporate docs
Subsidiaries
Koligo Therapeutics, Inc • Orgenesis CA, Inc • Orgenesis Switzerland Sarl • MIDA Biotech BV • Orgenesis Italy SRL • Orgenesis Ltd • Orgenesis Austria GmbH ...
IRS number
980583166
ORGS stock data
Latest filings (excl ownership)
S-3
Shelf registration
22 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Apr 24
10-K
2023 FY
Annual report
15 Apr 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
15 Apr 24
8-K
Entry into a Material Definitive Agreement
11 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Other Events
27 Mar 24
Transcripts
ORGS
Earnings call transcript
2023 Q2
11 Aug 23
ORGS
Earnings call transcript
2022 Q4
21 Mar 23
ORGS
Earnings call transcript
2022 Q3
14 Nov 22
ORGS
Earnings call transcript
2022 Q2
16 Aug 22
ORGS
Earnings call transcript
2021 Q4
31 Mar 22
ORGS
Earnings call transcript
2021 Q3
6 Nov 21
ORGS
Earnings call transcript
2021 Q3
4 Nov 21
ORGS
Earnings call transcript
2021 Q2
5 Aug 21
ORGS
Earnings call transcript
2021 Q1
10 May 21
ORGS
Earnings call transcript
2021 Q1
7 May 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 789.00 k | 789.00 k | 789.00 k | 789.00 k | 789.00 k | 789.00 k |
Cash burn (monthly) | 146.00 k | 306.50 k | 4.09 mm | 1.76 mm | 393.67 k | 2.09 mm |
Cash used (since last report) | 1.02 mm | 2.13 mm | 28.42 mm | 12.20 mm | 2.74 mm | 14.54 mm |
Cash remaining | -226.24 k | -1.34 mm | -27.63 mm | -11.42 mm | -1.95 mm | -13.75 mm |
Runway (months of cash) | -1.5 | -4.4 | -6.8 | -6.5 | -4.9 | -6.6 |
Institutional ownership, Q2 2023
17.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 25 |
Opened positions | 3 |
Closed positions | 1 |
Increased positions | 4 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 2.93 bn |
Total shares | 5.89 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
NewTech Investment | 1.62 mm | $3.65 mm |
New Dimensions Trading | 1.37 mm | $2.60 mm |
Vanguard | 924.81 k | $1.29 bn |
Bergen Asset Management | 710.12 k | $2.05 mm |
Redmond Asset Management | 579.98 k | $806.17 mm |
Geode Capital Management | 206.75 k | $287.39 mm |
BLK Blackrock | 132.57 k | $184.28 mm |
STT State Street | 88.66 k | $123.24 mm |
Walleye Capital | 71.24 k | $99.02 mm |
Renaissance Technologies | 45.90 k | $64.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Victor Miller | Common Stock | Option exercise | Acquire M | No | No | 0.5 | 25,000 | 12.50 k | 25,000 |
1 Apr 24 | Victor Miller | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.5 | 25,000 | 12.50 k | 175,000 |
1 Feb 24 | Jacob Safier | Common Stock (par value $0.01) | Buy | Acquire P | Yes | No | 0.3299 | 10,100 | 3.33 k | 3,110,100 |
2 Jan 24 | Victor Miller | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5 | 200,000 | 100.00 k | 200,000 |
20 Dec 23 | Philips Mario | Stock Option Common Stock | Grant | Acquire A | No | No | 0.45 | 13,750 | 6.19 k | 13,750 |
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
10 Apr 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
10 Apr 24
Germfree And Orgenesis Announce Asset Purchase And Strategic Partnership Intended To Revolutionize Cell And Gene Therapy Through Decentralized Production And Global Accessibility
10 Apr 24
12 Health Care Stocks Moving In Thursday's After-Market Session
4 Apr 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
3 Apr 24
Press releases
Orgenesis Provides Year End Business Update
15 Apr 24
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
10 Apr 24
Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic
31 Jan 24